These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9443611)

  • 1. Comparative disposition of the antineoplastic agent 9-nitrocampotothecin and the inactive isomer 12-nitro camptothecin in CASE-bearing nude mice: effect of route of administration on tissue distribution.
    Ahmed AE; Jacob S; Giovanella BC; Kozielski AJ; Liehr JG; Stehlin JS
    Cancer Chemother Pharmacol; 1997; 41(1):29-36. PubMed ID: 9443611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of route of administration on [3H]-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies.
    Ahmed AE; Jacob S; Giovanella BC; Kozielski AJ; Stehlin JS; Liehr JG
    Cancer Chemother Pharmacol; 1996; 39(1-2):122-30. PubMed ID: 8995509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of camptothecins administered orally.
    Liehr JG; Ahmed AE; Giovanella BC
    Ann N Y Acad Sci; 1996 Dec; 803():157-63. PubMed ID: 8993508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice.
    Koshkina NV; Gilbert BE; Waldrep JC; Seryshev A; Knight V
    Cancer Chemother Pharmacol; 1999; 44(3):187-92. PubMed ID: 10453719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of injection routes on pharmacokinetics and lactone/carboxylate equilibrium of 9-Nitrocamptothecin in rats.
    Chen J; Ping Q; Guo J; Liu M; Cai B
    Int J Pharm; 2007 Aug; 340(1-2):29-33. PubMed ID: 17446016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.
    Caiolfa VR; Zamai M; Fiorino A; Frigerio E; Pellizzoni C; d'Argy R; Ghiglieri A; Castelli MG; Farao M; Pesenti E; Gigli M; Angelucci F; Suarato A
    J Control Release; 2000 Mar; 65(1-2):105-19. PubMed ID: 10699275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.
    Slatter JG; Schaaf LJ; Sams JP; Feenstra KL; Johnson MG; Bombardt PA; Cathcart KS; Verburg MT; Pearson LK; Compton LD; Miller LL; Baker DS; Pesheck CV; Lord RS
    Drug Metab Dispos; 2000 Apr; 28(4):423-33. PubMed ID: 10725311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
    Kawato Y; Furuta T; Aonuma M; Yasuoka M; Yokokura T; Matsumoto K
    Cancer Chemother Pharmacol; 1991; 28(3):192-8. PubMed ID: 1855276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice.
    Choi SH; Tsuchida Y; Yang HW
    Cancer Lett; 1998 Feb; 124(1):15-21. PubMed ID: 9500186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice.
    Guichard S; Chatelut E; Lochon I; Bugat R; Mahjoubi M; Canal P
    Cancer Chemother Pharmacol; 1998; 42(2):165-70. PubMed ID: 9654118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver concentration of CPT-11, SN-38 and SN-38 GLU in intraperitoneal and intravenous administration of CPT-11].
    Maruyama M; Nagahama T; Yuasa Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1967-9. PubMed ID: 10560438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Nitro-20(S)-carbonate-camptothecin (NCP4), a novel prodrug of 9-nitrocamptothecin (9-NC), exhibits potent chemotherapeutic efficacy and improved safety against hepatocarcinoma.
    Zhou H; Zhang Y; Tian Y; Sun Y; Chen Y; Zhang Y; Zhu Q; Pan J; Qing C
    Eur J Pharmacol; 2022 May; 923():174898. PubMed ID: 35305999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.
    Chen J; Hu RR; Yang XX; Gu W; Tian R; Gong F; Luo L; Fang F; Chen ZP; Cai BC
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):925-9. PubMed ID: 23934323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
    Miki T; Sawada M; Nonomura N; Kojima Y; Okuyama A; Maeda O; Saiki S; Kotake T
    Eur Urol; 1997; 31(1):92-6. PubMed ID: 9032542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.
    Yan Z; Zhu Z; Li K; Chen P; Wang L; Huang C; Xue J; Liu M
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):955-61. PubMed ID: 21191594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative administration of camptothecin analogues.
    Glaberman U; Rabinowitz I; Verschraegen CF
    Expert Opin Drug Deliv; 2005 Mar; 2(2):323-33. PubMed ID: 16296757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.